mushroom

Codex DNA and RNAimmune Announce Collaboration to Optimize Development of Future mRNA Synthesis and Delivery Kits

Emerging technologies

Home » Emerging technologies

mushroom

mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity Capabilities

MELBOURNE, Australia and BOSTON, Nov. 17, 2021 /PRNewswire/ — mRNA Victoria, the agency of the Australian State of Victoria Government charged with building the State’s mRNA manufacturing and research...

mushroom

CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Automate Experimentation and Share Insights November 16, 2021 04:30 AM...

mushroom

Roswell Biotechnologies Unveils First Molecular Electronics Chip to Digitize Biology

mushroom

GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR

mushroom

Codex DNA Acquires Eton Bioscience

mushroom

DNA Script to Develop Next Generation of Enzymatic DNA Synthesis Printers with $2.2 Million Grant Award from the National Human Genome Research Institute of the NIH

bit.bio

bit.bio Raises in Excess of $100 Million in First Close of Series B Financing

mushroom

The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc.

mushroom

Arcaea, a Company Launched on the Ginkgo Bioworks Platform, Announces $78M Series A To Build a New Foundation For the Beauty Industry through Expressive Biology

Sphere Fluidics

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

mushroom

Selecta Biosciences and Ginkgo Bioworks Announce Partnership to Advance Treatments for Orphan and Rare Diseases

mushroom

Berkeley Lights Announces GSK Acquires Third Beacon® Optofluidic System to Expand Antibody Therapeutics Development

mushroom

DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform

mushroom

Molecular Assemblies Awarded NIH Phase I SBIR Grant to Develop a Fully Enzymatic DNA Synthesis Process to Propel Synthetic Biology